Stock DNA
Diversified Commercial Services
INR 15 Cr (Micro Cap)
NA (Loss Making)
18
0.00%
0.00
-0.71%
0.19
Total Returns (Price + Dividend) 
Photon Capital for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Is Photon Capital overvalued or undervalued?
As of 23 October 2025, Photon Capital's valuation grade has moved from very expensive to risky, indicating a significant shift in its financial outlook. The company is currently considered overvalued. Key ratios reveal a troubling picture, with a PE ratio of -29.24, an EV to EBIT of 17.40, and a Price to Book Value of 0.21, suggesting that the market is pricing in significant risks associated with its earnings and capital structure. In comparison to its peers, Photon Capital's valuation metrics stand out negatively. For instance, Bajaj Finance has a PE ratio of 39.07 and an EV to EBITDA of 20.55, while Life Insurance boasts a much more attractive PE ratio of 11.68 and an EV to EBITDA of 9.11. These comparisons highlight that Photon Capital is not only underperforming relative to its peers but also carries a higher risk profile. Despite a strong recent performance against the Sensex, with a year-to-date ret...
Read MoreIs Photon Capital overvalued or undervalued?
As of 20 October 2025, Photon Capital's valuation grade has moved from expensive to very expensive, indicating a significant deterioration in its valuation outlook. The company is currently deemed overvalued. Key ratios highlight this assessment, with a PE ratio of -30.77, an EV to EBIT of 16.55, and a price to book value of 0.22. When compared to peers, Photon Capital stands out unfavorably; for instance, Bajaj Finance has a PE ratio of 38.6 and an EV to EBITDA of 20.38, while Life Insurance boasts a more attractive EV to EBITDA of 9.01. The negative capital employed and a return on equity (ROE) of -0.71% further underscore Photon Capital's challenges. Despite its recent stock performance, which has outpaced the Sensex in various timeframes, the underlying valuation metrics suggest that the stock is not justified at its current price of 111.82....
Read MoreIs Photon Capital overvalued or undervalued?
As of 17 October 2025, the valuation grade for Photon Capital has moved from risky to expensive. The company is currently overvalued, as indicated by its negative PE ratio of -27.79, an EV to EBITDA ratio of -12.49, and a ROE of -26.41%. In comparison to its peers, Bajaj Finance has a PE ratio of 38.21 and Bajaj Finserv stands at 34.94, both categorized as expensive, while Life Insurance is notably attractive with a PE of 11.49. Despite its recent stock performance, which has outpaced the Sensex with a 1-week return of 18.33% compared to 1.76%, the underlying financial metrics suggest significant concerns regarding profitability and valuation. The negative ratios and high EV metrics indicate that Photon Capital is not only overvalued but also struggling to generate positive returns, reinforcing the need for caution among investors....
Read More Announcements 
Shareholders Meeting/EGM On Dec.05.2025
11-Nov-2025 | Source : BSENotice of EGM of the company
Results - Financial Results For Sept 30 2025
17-Oct-2025 | Source : BSEResults - Financial Results for Sept 30 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 17.10.2025.
17-Oct-2025 | Source : BSEWith reference to the above-mentioned subject please note that the Board of directors in their Board meeting held on 17.10.2025 has inter-alia transacted the following business: 1. Approval of the unaudited standalone and consolidated financial statements for the second quarter ended 30.09.2025. 2. Taken note of Limited Review Report for the Quarter ended 30.09.2025. Further it is to inform that the Board meeting has commenced at 03:00 p.m. and the meeting was concluded at 4:00 pm on 17.10.2025. This is for your information and records.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Tejaswy Nandury (32.99%)
None
24.67%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -33.33% vs 0.00% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 833.33% vs 91.89% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -16.67% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 280.00% vs -16.67% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 0.00% vs 20.00% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -633.33% vs 126.09% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -4.00% vs 19.05% in Mar 2024
YoY Growth in year ended Mar 2025 is 65.15% vs -435.14% in Mar 2024






